{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2205,"total_is_capped":false,"direct_labels_cover":5,"predictions_cover":2205,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"606793aed8c0","filters":{"venue":"Clinical Cancer Research"}},"results":[{"id":"W2170602872","doi":"10.1158/1078-0432.ccr-06-3045","title":"Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5106,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Hazard ratio; Internal medicine; Oncology; Confidence interval; Cancer; Cohort; Proportional hazards model; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.1312351163977038,"gpt":0.5259002702839296,"spread":0.3946651538862258,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00340718,0.0001893721,0.0004561743,0.00007383918,0.0001435283,0.00001813836,0.0003255671,0.0002941618,0.00008401339],"category_scores_gemma":[0.0009079716,0.0001546357,0.0001793383,0.0002334754,0.00111542,0.000006965329,0.0004451926,0.0006436908,0.000003856055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005438718,"about_ca_system_score_gemma":0.0003749116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002649976,"about_ca_topic_score_gemma":0.004660538,"domain_scores_codex":[0.9970372,0.000466941,0.0007465251,0.000757386,0.0004413847,0.0005505235],"domain_scores_gemma":[0.9975478,0.0009073639,0.0001859005,0.0004354516,0.0006461379,0.0002773291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002151294,0.0002461917,0.8175543,0.00004961474,0.0002455958,0.000007755688,0.00006920548,6.366585e-7,0.0003372695,0.00005000526,0.006757478,0.1725307],"study_design_scores_gemma":[0.002098141,0.000470621,0.9881704,0.0001391778,0.00003568972,0.00001146774,0.0002226477,0.000001428201,0.004686452,0.0001180468,0.003882282,0.0001636247],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98881,0.006998175,0.00006157717,0.002009142,0.0006565486,0.0004022981,0.0006063332,0.00001027779,0.0004456286],"genre_scores_gemma":[0.9696975,0.02799249,0.0001352123,0.0002332888,0.001359867,0.00008758769,0.00001914255,0.00002400919,0.0004509198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1723671,"threshold_uncertainty_score":0.6305859,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099335989","doi":"10.1158/1078-0432.ccr-04-0220","title":"Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":2657,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital; McGill University; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; University of North Carolina at Chapel Hill; Michael Smith Health Research BC","keywords":"Cytokeratin; Tissue microarray; Immunohistochemistry; Basal (medicine); Breast cancer; Pathology; Breast carcinoma; Estrogen receptor; Biology; Estrogen; Oncology; Internal medicine; Medicine; Cancer; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1167435459886284,"gpt":0.4468597379217741,"spread":0.3301161919331458,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001903635,0.0001105747,0.0005127061,0.0000776619,0.00008217088,0.000007424384,0.0002531883,0.0002585954,0.0001435157],"category_scores_gemma":[0.000772782,0.00007389297,0.0002532313,0.0004462755,0.001682245,0.00004690007,0.0003103237,0.000924135,0.000007437261],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001021864,"about_ca_system_score_gemma":0.0016026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006224448,"about_ca_topic_score_gemma":0.00004927153,"domain_scores_codex":[0.9974731,0.0003567355,0.0009278,0.0003669838,0.0005959029,0.0002794501],"domain_scores_gemma":[0.9976038,0.0005648023,0.0002076395,0.0006231727,0.0007715005,0.0002290621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001585818,0.0006138724,0.8708848,0.0001927567,0.00007250088,0.00001114442,0.00009352226,1.992104e-7,0.1182445,0.0002911126,0.0002351311,0.007774597],"study_design_scores_gemma":[0.002507979,0.0005042164,0.9881701,0.0003301115,0.00006665562,0.00003681835,0.00005521015,0.000009558313,0.007855684,0.0001747098,0.0002218327,0.00006705587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944146,0.0004041635,0.000008970306,0.00411017,0.0002758279,0.0004763971,0.00005495739,0.000007434554,0.0002474339],"genre_scores_gemma":[0.9983732,0.0006847586,0.00005032107,0.000275362,0.0003170423,0.00002209882,0.00001591045,0.00002088498,0.0002404002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1172853,"threshold_uncertainty_score":0.6198301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117878645","doi":"10.1158/1078-0432.ccr-09-0265","title":"Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1648,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; York University; Chemotherapy Foundation; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Abscopal effect; Radiation therapy; Medicine; CD8; Cancer research; Antibody; Immunotherapy; Growth inhibition; Nasopharyngeal carcinoma; Carcinoma; Dose fractionation; Regimen; Immune system; Oncology; Internal medicine; Immunology; Cell growth; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1219258312480413,"gpt":0.4906271966923983,"spread":0.3687013654443569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004085281,0.0003704131,0.001027217,0.0003782412,0.000330253,0.000145827,0.0004523801,0.0004528555,0.001149314],"category_scores_gemma":[0.00055157,0.0002637548,0.000263881,0.001013991,0.0009102729,0.000313486,0.00003994117,0.001774427,0.00004717086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004257463,"about_ca_system_score_gemma":0.0009944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001643023,"about_ca_topic_score_gemma":0.00007898942,"domain_scores_codex":[0.9947349,0.001124049,0.0009482299,0.0008820029,0.001409165,0.0009016391],"domain_scores_gemma":[0.9961854,0.001577738,0.0002269997,0.000871111,0.0006422939,0.0004965005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0931854,0.001893324,0.02667197,0.00007414523,0.000557245,0.0002080646,0.000205833,0.000003811416,0.7958717,0.000007674221,0.001730254,0.07959054],"study_design_scores_gemma":[0.03568558,0.05304797,0.7715359,0.0006714952,0.0001138336,0.00006426429,0.0001284587,0.0003712729,0.1254942,0.00005284534,0.01221507,0.0006191226],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868281,0.00272725,0.00002518188,0.0075472,0.0004825426,0.001532249,0.00003561607,0.0001937503,0.0006281238],"genre_scores_gemma":[0.9926823,0.002829348,0.0002158802,0.00234718,0.0008515308,0.00008144534,0.0002211486,0.00007443286,0.0006966804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7448639,"threshold_uncertainty_score":0.9999815,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131593373","doi":"10.1158/1078-0432.ccr-08-0196","title":"Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1511,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous ovarian cancer; Ovarian cancer; Cancer; Medicine; Oncology; Ovary; Internal medicine; Biology; Cancer research; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.4324944750005766,"gpt":0.571834478133757,"spread":0.1393400031331804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003089142,0.0002331984,0.001191708,0.0003454576,0.0001416817,0.00002145891,0.0002661064,0.0003266332,0.0005273244],"category_scores_gemma":[0.002909845,0.000185897,0.0003446699,0.001097797,0.0007755532,0.00005477591,0.0002976453,0.001079534,0.00005545505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002410811,"about_ca_system_score_gemma":0.001213302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003752865,"about_ca_topic_score_gemma":0.0003720825,"domain_scores_codex":[0.9955547,0.0003386132,0.001487183,0.0009188719,0.001040998,0.0006596665],"domain_scores_gemma":[0.9950854,0.002200719,0.0001666467,0.0007699525,0.0008211695,0.0009561336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001585767,0.001447595,0.9513943,0.000127169,0.0004608959,0.0002713319,0.0001047839,0.000009527462,0.0006932477,0.0002316045,0.002709814,0.04096399],"study_design_scores_gemma":[0.008361273,0.002394855,0.9657253,0.0002322391,0.0001544199,0.00003129343,0.00002958566,0.00003035602,0.0008883349,0.00004845121,0.0219179,0.000186011],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9783769,0.00509139,0.0001417394,0.0135802,0.000665146,0.001250734,0.0001122877,0.00003491781,0.0007466815],"genre_scores_gemma":[0.9817988,0.01178929,0.002364463,0.001868071,0.0008889075,0.0003840753,0.000007947798,0.00005407721,0.0008443767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04077798,"threshold_uncertainty_score":0.758066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102596641","doi":"10.1158/1078-0432.ccr-07-1658","title":"Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Progesterone receptor; Internal medicine; Medicine; Cytokeratin; Anthracycline; Tissue microarray; Basal (medicine); Biomarker; Estrogen receptor; Cancer; Proportional hazards model; Pathology; Surrogate endpoint; Immunohistochemistry; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1088655616907161,"gpt":0.4191382268596101,"spread":0.310272665168894,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008299579,0.0003750064,0.000537647,0.00009248918,0.0006999815,0.00005261937,0.0005288535,0.0003397425,0.000328083],"category_scores_gemma":[0.0009431625,0.0002887752,0.0002832598,0.0005522183,0.002224974,0.00001507105,0.0004580745,0.0005503301,0.00007113998],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002514965,"about_ca_system_score_gemma":0.001558963,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008758447,"about_ca_topic_score_gemma":0.001852313,"domain_scores_codex":[0.9958296,0.0007063914,0.0005883815,0.001181165,0.0007106559,0.0009837694],"domain_scores_gemma":[0.9974704,0.0006377487,0.0001283752,0.0006231191,0.0007447423,0.000395597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006416711,0.001168381,0.63628,0.00008557917,0.002009267,0.00006655515,0.0005182787,0.00002053827,0.007977032,0.00001946683,0.3314729,0.01396532],"study_design_scores_gemma":[0.007818987,0.001280431,0.9399307,0.0001925923,0.0001792941,0.00003523274,0.0004444064,0.00008195618,0.009824059,0.0001869746,0.0391794,0.0008459341],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750759,0.009944689,0.00003262978,0.0107007,0.0009005551,0.001107697,0.00168647,0.00004764022,0.0005037364],"genre_scores_gemma":[0.9847789,0.009349249,0.0002270007,0.0006880739,0.000996194,0.001198288,0.0001643243,0.00008495912,0.002513028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3036508,"threshold_uncertainty_score":0.9999564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152963742","doi":"10.1158/1078-0432.ccr-08-2242","title":"Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1111,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sarcopenia; Capecitabine; Breast cancer; Internal medicine; Oncology; Metastatic breast cancer; Toxicity; Anthracycline; Cancer; Taxane; Chemotherapy; Surgery; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1365655502381877,"gpt":0.5512843355968937,"spread":0.414718785358706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001305095,0.0001246578,0.0005607127,0.0002096412,0.00007215831,0.00001389776,0.00008686858,0.00005213462,0.0009591759],"category_scores_gemma":[0.000313607,0.00009039095,0.00005708165,0.0004306025,0.0001256874,0.00005239532,0.00003997399,0.0003270821,0.00003036539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004311652,"about_ca_system_score_gemma":0.0004676725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006536277,"about_ca_topic_score_gemma":0.0002277585,"domain_scores_codex":[0.9977558,0.0002791031,0.0006430959,0.0003898102,0.0004977645,0.0004343718],"domain_scores_gemma":[0.9986402,0.0003345733,0.00009362993,0.000202405,0.0003061132,0.0004231046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004387282,0.00278263,0.2349114,0.0002135747,0.00002022485,0.00004632933,0.0003344367,4.843026e-7,0.003103771,0.000003873308,0.000942899,0.7532532],"study_design_scores_gemma":[0.008138393,0.00520137,0.9778817,0.002791945,0.00001860389,0.00001212848,0.00003457149,0.0002205238,0.003090684,0.00009339675,0.002402543,0.0001141252],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822142,0.0006598968,7.409954e-7,0.01528766,0.00004134659,0.001477743,0.00003295877,0.00001231632,0.0002731532],"genre_scores_gemma":[0.9951397,0.001585761,0.0006138072,0.001777006,0.0001297063,0.0002079193,0.000004435501,0.00001704921,0.0005246607],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.753139,"threshold_uncertainty_score":0.9999541,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093783077","doi":"10.1158/1078-0432.ccr-06-2309","title":"Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1075,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medicine; Bevacizumab; Irinotecan; Glioma; Surgery; Internal medicine; Chemotherapy; Gastroenterology; Cancer; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.2874148997796409,"gpt":0.5805459813262088,"spread":0.2931310815465679,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044257,0.0001082297,0.0004911741,0.0003507585,0.0000690227,0.000009201764,0.00009951938,0.00014189,0.0001631339],"category_scores_gemma":[0.0009357502,0.00008036046,0.0001194766,0.0005703453,0.0003560467,0.00002910802,0.0001615267,0.0004963905,0.000007314349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001699167,"about_ca_system_score_gemma":0.0003055321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006654196,"about_ca_topic_score_gemma":0.000716592,"domain_scores_codex":[0.9974654,0.0001888073,0.0008193247,0.0004058882,0.0006524184,0.0004681368],"domain_scores_gemma":[0.9980808,0.0009261773,0.00008328607,0.0003395473,0.0002271341,0.0003430408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.15647,0.02817805,0.02471254,0.000137303,0.0001128797,0.001189417,0.000234523,2.680051e-7,0.002714444,0.000403114,0.00159165,0.7842557],"study_design_scores_gemma":[0.6986326,0.1171311,0.1119668,0.001227927,0.0001420205,0.0000426451,0.0003149447,0.00009493876,0.04771168,0.0006574137,0.02178612,0.0002917542],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993359,0.002578462,0.000001985925,0.002116848,0.000264248,0.001086727,0.00001871641,0.000009085159,0.0005649733],"genre_scores_gemma":[0.9976918,0.001663522,0.00007147694,0.00003957359,0.0003395111,0.0001145274,0.00000666495,0.00001389404,0.00005908756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.783964,"threshold_uncertainty_score":0.3277005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159360580","doi":"10.1158/1078-0432.ccr-04-2245","title":"Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":831,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Imatinib; GiST; PDGFRA; Medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Mutation; Cancer research; Drug resistance; Exon; Stromal tumor; Tyrosine kinase; Gene mutation; Internal medicine; Stromal cell; Biology; Cancer; Gene; Genetics; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.1862819145099767,"gpt":0.5172058367657747,"spread":0.330923922255798,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00260587,0.0002483422,0.0005727046,0.0002940495,0.0001597388,0.00006918684,0.0003374041,0.00005091545,0.00110106],"category_scores_gemma":[0.003672493,0.0002172263,0.0001765366,0.0009176829,0.0004770884,0.0002123862,0.0002224585,0.001174296,0.0005654086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008560398,"about_ca_system_score_gemma":0.00160269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004082089,"about_ca_topic_score_gemma":0.001644701,"domain_scores_codex":[0.9948777,0.0005477676,0.0009940777,0.0008716196,0.001374546,0.001334319],"domain_scores_gemma":[0.996721,0.001045348,0.0001044732,0.0005850539,0.0006886561,0.000855501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03736393,0.006037672,0.7981738,0.0008522987,0.0001847209,0.01961084,0.0008959702,0.000273396,0.01784801,0.001073505,0.0589931,0.05869275],"study_design_scores_gemma":[0.01371064,0.009873384,0.9460534,0.003170251,0.00004056168,0.001360402,0.0006385015,0.0006289557,0.01000217,0.001041568,0.01303124,0.0004488963],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791341,0.0004816688,0.0001929897,0.01436947,0.00005262659,0.001439069,0.00008582276,0.00006522665,0.004178972],"genre_scores_gemma":[0.9412784,0.00003929958,0.05471607,0.0007943728,0.0007326884,0.0004837679,0.00004883944,0.0000484209,0.001858126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1478796,"threshold_uncertainty_score":0.9998121,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161109798","doi":"10.1158/1078-0432.ccr-10-1282","title":"A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":824,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; BC Cancer Agency","keywords":"Breast cancer; Oncology; Immunohistochemistry; Internal medicine; Medicine; Estrogen receptor; Hazard ratio; Progesterone receptor; Tamoxifen; Proportional hazards model; Subtyping; Hormone receptor; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.07446867362571363,"gpt":0.4895050496537869,"spread":0.4150363760280733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009553651,0.0002703776,0.0006731339,0.00007945846,0.0001366035,0.00002636167,0.0003051883,0.0004021098,0.00007737982],"category_scores_gemma":[0.0005695552,0.0002140032,0.0001300736,0.0003550249,0.001731471,0.00001034418,0.0003386289,0.001191575,0.000002686661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009818353,"about_ca_system_score_gemma":0.0006460445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002859514,"about_ca_topic_score_gemma":0.002392602,"domain_scores_codex":[0.9970893,0.0003506158,0.0008193608,0.0008305003,0.0003673026,0.0005428664],"domain_scores_gemma":[0.9978561,0.0006068649,0.0002412403,0.0004647508,0.00059427,0.0002367318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002575222,0.0006135911,0.9529399,0.00005286975,0.0003494731,0.000005351794,0.0001134076,0.000002445638,0.03173231,0.000008856811,0.0002789931,0.01132754],"study_design_scores_gemma":[0.002136542,0.0005767376,0.9609632,0.000225758,0.00007183306,0.000006721594,0.0002378073,0.0000110995,0.03524931,0.000009604872,0.0002801559,0.0002312235],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962038,0.002246396,0.000003441342,0.0004723968,0.0001873605,0.0005328968,0.0002397247,0.00001305877,0.0001008596],"genre_scores_gemma":[0.9974794,0.001583362,0.0001301266,0.00002838676,0.0003731005,0.0002191859,0.00009384598,0.00004099299,0.00005158771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01109632,"threshold_uncertainty_score":0.8726796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2910164268","doi":"10.1158/1078-0432.ccr-18-0432","title":"CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":672,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Deutsche Krebshilfe","keywords":"Cancer; Antigen; Medicine; Cancer research; Solid tumor; Pathology; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1480627897940606,"gpt":0.497207940263481,"spread":0.3491451504694204,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01206825,0.000493136,0.001605039,0.0004776772,0.0003634584,0.000180812,0.0006691451,0.0005957026,0.00333136],"category_scores_gemma":[0.002659652,0.0004238976,0.0005544425,0.001371895,0.001193161,0.0002350091,0.0008277033,0.004511038,0.0003507452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00051293,"about_ca_system_score_gemma":0.003054891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001131936,"about_ca_topic_score_gemma":0.0002001922,"domain_scores_codex":[0.9897418,0.002169554,0.001605605,0.001922407,0.002433484,0.002127166],"domain_scores_gemma":[0.99078,0.005341197,0.000333242,0.001130915,0.0009744923,0.00144013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004396376,0.0008500959,0.6721124,0.0007020161,0.0002465571,0.0003221736,0.0001841426,0.00004701467,0.1936791,0.00000780114,0.01127073,0.1161815],"study_design_scores_gemma":[0.01802466,0.006515795,0.8512455,0.001424759,0.0002192344,0.0000481983,0.0009443463,0.0068663,0.07905229,0.0002894633,0.03352242,0.00184698],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853399,0.003253832,0.00001121431,0.005847967,0.0007036951,0.002815039,0.00008756288,0.0001104155,0.001830327],"genre_scores_gemma":[0.9643725,0.02332008,0.0001365617,0.0008407559,0.002875477,0.000290526,0.00001821236,0.0001530063,0.007992871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1791331,"threshold_uncertainty_score":0.9998213,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107089530","doi":"10.1158/1078-0432.ccr-09-1525","title":"Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":664,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overweight; Sarcopenia; Hazard ratio; Pancreatic cancer; Internal medicine; Body mass index; Confidence interval; Underweight; Weight loss; Cancer; Gastroenterology; Sarcopenic obesity; Obesity; Cachexia","retraction":null,"screen_n_in":null,"score":{"opus":0.4335735860926836,"gpt":0.6035947952703241,"spread":0.1700212091776405,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001467708,0.0001668213,0.0005899873,0.0003807346,0.00009594913,0.00002756888,0.0002170583,0.0002119871,0.004394742],"category_scores_gemma":[0.0008580355,0.0001277151,0.00006960631,0.0009159259,0.0001849315,0.0002336897,0.00005589412,0.001526414,0.00006673476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006820126,"about_ca_system_score_gemma":0.001562109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0024917,"about_ca_topic_score_gemma":0.00907589,"domain_scores_codex":[0.9959754,0.0007230022,0.0009668643,0.0006631901,0.0008291943,0.0008423391],"domain_scores_gemma":[0.9977267,0.0005632573,0.00008309627,0.0004911965,0.0003335612,0.0008021905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003409307,0.001942283,0.9207131,0.0002648902,0.000008079166,0.000339437,0.001296869,0.000002559012,0.0002003087,0.00002777806,0.001800428,0.06999494],"study_design_scores_gemma":[0.004716495,0.004026636,0.9773545,0.001777646,0.00001197426,0.00000378996,0.0004389256,0.0007690219,0.0001845234,0.0002888608,0.01025626,0.0001713266],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883173,0.001300524,9.71788e-7,0.008078652,0.0001804707,0.00165766,0.00004694536,0.00003525717,0.0003822586],"genre_scores_gemma":[0.9886457,0.003636153,0.0002769572,0.006124395,0.0004422001,0.0003521007,0.00001794176,0.00002709547,0.0004774989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06982362,"threshold_uncertainty_score":0.9965154,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2780727948","doi":"10.1158/1078-0432.ccr-17-2994","title":"Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":636,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Health Network; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; Canadian Friends of Tel Aviv University; Ontario Institute for Cancer Research; Division of Cancer Prevention, National Cancer Institute","keywords":"Pancreatic cancer; Transcriptome; Medicine; Clinical endpoint; Oncology; FOLFIRINOX; Biopsy; Cancer; Precision medicine; Internal medicine; Biology; Pathology; Gene; Clinical trial; Gene expression; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.4546718383273811,"gpt":0.6054100502091737,"spread":0.1507382118817926,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.009345494,0.0002572011,0.001490176,0.0001038686,0.001575148,0.0001227029,0.001518534,0.0003956417,0.0005951469],"category_scores_gemma":[0.02517926,0.0001522707,0.0003027052,0.0001666618,0.002907869,0.0001337772,0.0005185443,0.001717381,0.00009498359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005090208,"about_ca_system_score_gemma":0.002223183,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01544387,"about_ca_topic_score_gemma":0.002625958,"domain_scores_codex":[0.9941498,0.0009769722,0.001451324,0.001018816,0.001400565,0.001002496],"domain_scores_gemma":[0.9753895,0.01999957,0.0004898312,0.002333515,0.00117107,0.0006164634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4804159,0.0005797304,0.2598328,0.00009529071,0.0009000637,0.00005767238,0.001040208,0.000009903395,0.001207898,0.0002404368,0.120811,0.1348091],"study_design_scores_gemma":[0.2097079,0.008330631,0.636948,0.001328687,0.0005641895,0.000002365852,0.0003414022,0.002730445,0.0001707699,0.002975018,0.1366368,0.0002637125],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9203951,0.002081472,0.0001088744,0.06685285,0.00132314,0.005209549,0.0004783419,0.00003625708,0.003514456],"genre_scores_gemma":[0.9663473,0.01340186,0.001041471,0.0006286595,0.008760463,0.002379405,0.0001018433,0.00006590853,0.007273089],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3771153,"threshold_uncertainty_score":0.9998056,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127206464","doi":"10.1158/1078-0432.ccr-06-3067","title":"Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":613,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Toxicity; Body surface area; Lean body mass; Fluorouracil; Population; Medicine; Chemotherapy; Internal medicine; Body weight","retraction":null,"screen_n_in":null,"score":{"opus":0.3008704198020518,"gpt":0.6177990339498245,"spread":0.3169286141477727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006892827,0.00009403253,0.0003796633,0.0002064992,0.0001356632,0.00001429383,0.0001555381,0.0001971433,0.0009362501],"category_scores_gemma":[0.0002072278,0.00008173571,0.0001148551,0.000307879,0.0003158334,0.00006188764,0.0000355343,0.0009374587,0.00003489501],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002418554,"about_ca_system_score_gemma":0.0005735701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003853836,"about_ca_topic_score_gemma":0.0001357554,"domain_scores_codex":[0.997148,0.0003124197,0.0007693201,0.0003470043,0.0009474895,0.000475801],"domain_scores_gemma":[0.9977008,0.0006381111,0.0001160042,0.0003788923,0.0006238017,0.0005424445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02279964,0.007617776,0.4949119,0.001377994,0.00008084702,0.0004231569,0.0004336215,0.000002750624,0.1516334,0.0009430962,0.003099762,0.3166761],"study_design_scores_gemma":[0.009207463,0.005016729,0.7259624,0.0007346889,0.00002345901,0.00002498893,0.0002150308,0.0009073796,0.2481639,0.0007995589,0.008768016,0.0001763612],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923658,0.0001980453,0.0004416955,0.004637257,0.0001757447,0.0006290071,0.000008693261,0.00003446156,0.001509261],"genre_scores_gemma":[0.9946965,0.0003698673,0.0009720255,0.003153039,0.0005647956,0.00002871061,0.00001718888,0.00002030407,0.000177596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3164997,"threshold_uncertainty_score":0.9999771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2234923158","doi":"10.1158/1078-0432.ccr-15-2762","title":"Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":606,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Battle Creek Community Foundation; U.S. Department of Defense","keywords":"Ovarian cancer; Biology; CD8; Antigen; CD20; Cancer research; Tumor-infiltrating lymphocytes; Cytotoxic T cell; Immunology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.06570438379216074,"gpt":0.3745017896595933,"spread":0.3087974058674325,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002901363,0.0003093329,0.0006470944,0.0002938493,0.0003896968,0.00006664778,0.0004577913,0.000462214,0.001133981],"category_scores_gemma":[0.001242107,0.0001969402,0.0001030896,0.000461546,0.001407457,0.0001841321,0.0001869317,0.001067557,0.00004870103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003434347,"about_ca_system_score_gemma":0.001255118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001527515,"about_ca_topic_score_gemma":0.00129336,"domain_scores_codex":[0.9939426,0.003206716,0.0008126206,0.0007710123,0.0001935774,0.001073485],"domain_scores_gemma":[0.9940491,0.004971028,0.0002329457,0.0004121888,0.0002518814,0.00008287187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0093697,0.0002409591,0.4295466,0.00004151739,0.0001995818,0.00008957888,0.000217904,0.000001154009,0.5447741,0.00001443556,0.0009100961,0.01459436],"study_design_scores_gemma":[0.01005286,0.0009788014,0.5493817,0.001016399,0.00003195641,0.00004798149,0.0003110444,0.00000502625,0.4306022,0.00004693805,0.007116624,0.0004084901],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862896,0.01063926,0.000003206226,0.001642284,0.0003679767,0.000715634,0.0002206146,0.00004788853,0.00007350028],"genre_scores_gemma":[0.9909308,0.003201804,0.00002648622,0.0002604326,0.00007716598,0.0003824934,0.000009080382,0.00005862265,0.00505313],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1198351,"threshold_uncertainty_score":0.9997791,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161609794","doi":"10.1158/1078-0432.ccr-07-4921","title":"Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":605,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; European Commission","keywords":"Biology; Cancer research; Carcinogenesis; Epigenetics; Clear cell; Cancer; DNA methylation; Clear cell renal cell carcinoma; CpG site; Germline mutation; Mutation; Gene; Pathology; Renal cell carcinoma; Medicine; Genetics; Gene expression; Carcinoma","retraction":null,"screen_n_in":null,"score":{"opus":0.2289285019524419,"gpt":0.477626979164216,"spread":0.2486984772117741,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002234419,0.0001253155,0.0004307045,0.000292792,0.0001144012,0.00001356694,0.0001903548,0.000151347,0.0002314844],"category_scores_gemma":[0.0005734176,0.0001077728,0.0001746166,0.0006153625,0.0004676837,0.00007536227,0.0000944893,0.0008160827,0.00008978113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003581319,"about_ca_system_score_gemma":0.0009795928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00112321,"about_ca_topic_score_gemma":0.0001892219,"domain_scores_codex":[0.9967041,0.000439877,0.001183882,0.0005171462,0.0007375986,0.0004173915],"domain_scores_gemma":[0.9979101,0.0004758014,0.0001686515,0.0006195482,0.0005623282,0.0002635442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005874164,0.00295025,0.212611,0.0003170694,0.0001014208,0.0005267998,0.001105657,0.0001010929,0.7649525,0.00007665225,0.003184774,0.008198574],"study_design_scores_gemma":[0.00376609,0.001891496,0.5170361,0.0001222223,0.00003672613,0.00002515713,0.0001102608,0.00235875,0.4739117,0.00009168524,0.0005193381,0.000130521],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962585,0.0008726262,0.00004984414,0.0009069416,0.0001278579,0.0008502686,0.00002163532,0.00001721683,0.0008951406],"genre_scores_gemma":[0.9944755,0.00105854,0.0002789905,0.00006408912,0.0003622073,0.0001636694,0.00004560799,0.00002896265,0.003522367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.304425,"threshold_uncertainty_score":0.4394846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101657563","doi":"10.1158/1078-0432.ccr-05-1029","title":"The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":600,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Aging","funders":"","keywords":"Missense mutation; Breast cancer; Exon; Mutation; Germline mutation; Biology; Gene; Cancer research; Genetics; Cancer; Internal medicine; Oncology; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1031150109177961,"gpt":0.4938499658135281,"spread":0.3907349548957321,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00349108,0.0001794108,0.0006270216,0.0001711123,0.0001906169,0.00002937947,0.0003550028,0.000262453,0.0001635833],"category_scores_gemma":[0.001019611,0.0001174643,0.0002261838,0.001102741,0.001455793,0.00006383852,0.0001448549,0.001593887,0.00003247483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004169031,"about_ca_system_score_gemma":0.002449079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004971013,"about_ca_topic_score_gemma":0.004629749,"domain_scores_codex":[0.9949108,0.0009050523,0.001574512,0.0005720269,0.001357788,0.0006798425],"domain_scores_gemma":[0.9954066,0.002151878,0.0002694402,0.0007853864,0.001116905,0.0002697501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001923044,0.001376471,0.9542255,0.0001047454,0.0001662016,0.0000430547,0.00005084859,0.0005174259,0.0001727161,0.0002841902,0.003600017,0.03753573],"study_design_scores_gemma":[0.006685019,0.0007832308,0.9880539,0.0005209447,0.00009952076,0.000006211014,0.00004785775,0.0007245929,0.0003180584,0.0005300937,0.002101189,0.0001294221],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911194,0.001644298,0.00005093105,0.00441048,0.0004034127,0.001362963,0.0001564696,0.00002767664,0.0008243585],"genre_scores_gemma":[0.9967853,0.001376809,0.000273559,0.0001620946,0.0005508043,0.0003528831,0.00004509494,0.00005666044,0.0003968155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03740631,"threshold_uncertainty_score":0.7514718,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2939485990","doi":"10.1158/1078-0432.ccr-19-0624","title":"Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":597,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Medicine; Cancer; Cell-free fetal DNA; Cell; Oncology; Pathology; Bioinformatics; Internal medicine; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.06481302330116015,"gpt":0.4362565269020118,"spread":0.3714435036008517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00206468,0.0002723379,0.0009102175,0.0003067227,0.000061978,0.00004707679,0.0009552669,0.0002557436,0.0002792],"category_scores_gemma":[0.0004414186,0.0002476141,0.0004264364,0.0010481,0.0003599574,0.000007767684,0.0008939533,0.0005577331,0.0000218602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001214384,"about_ca_system_score_gemma":0.001124168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003965237,"about_ca_topic_score_gemma":0.007022989,"domain_scores_codex":[0.9955755,0.0006589374,0.001299521,0.001190786,0.0005738269,0.0007014218],"domain_scores_gemma":[0.9957336,0.001128149,0.0003160641,0.001468298,0.0009143928,0.0004394838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002437199,0.0008071691,0.9825832,0.0001746338,0.00103319,0.000007814171,0.00005097274,0.001218924,0.004089257,0.000001104051,0.005362188,0.002234397],"study_design_scores_gemma":[0.007293513,0.00113751,0.9851413,0.00005666979,0.0004007391,5.166934e-8,0.0001329243,0.0006724042,0.002783321,0.00001159281,0.002062629,0.0003073954],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949791,0.001810369,0.000178712,0.0001458743,0.0004051194,0.001627651,0.0005942362,0.000004601116,0.0002542853],"genre_scores_gemma":[0.9958008,0.002377161,0.0007666412,0.0003846762,0.0001582571,0.0001840271,0.0001414048,0.00004759563,0.0001394671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004856314,"threshold_uncertainty_score":0.9999976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168841302","doi":"10.1158/1078-0432.ccr-06-0462","title":"Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":584,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Gefitinib; Erlotinib; Epidermal growth factor receptor; Lung cancer; Medicine; Exon; Erlotinib Hydrochloride; Internal medicine; Oncology; Mutation; Point mutation; Cancer research; Cancer; Biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.09555870628366898,"gpt":0.4421776627540716,"spread":0.3466189564704026,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007054659,0.0002700491,0.000741532,0.0002944828,0.0001768658,0.00003073741,0.0001506397,0.0002393796,0.0004187336],"category_scores_gemma":[0.0006262294,0.0001755263,0.0001060549,0.001259884,0.0003548791,0.0001274714,0.00004137557,0.0007322975,0.000006178212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009557963,"about_ca_system_score_gemma":0.001744686,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01536161,"about_ca_topic_score_gemma":0.03673966,"domain_scores_codex":[0.9963158,0.0005585487,0.0008835108,0.0006603707,0.0009032055,0.0006785153],"domain_scores_gemma":[0.995999,0.001190272,0.0004280214,0.0002751647,0.001825065,0.000282432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004338038,0.002557354,0.9901222,0.0002573708,0.0002617722,0.00005466775,0.0003205388,0.00007979645,0.00011422,0.000007793925,0.0009974502,0.0008888219],"study_design_scores_gemma":[0.0153547,0.002440531,0.9791524,0.0009285022,0.0002869193,8.026468e-7,0.0002195647,0.0001865279,0.0010789,0.000007956555,0.0001314965,0.0002117197],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942827,0.0002213896,0.00001920961,0.0009471248,0.0001068707,0.002921811,0.0007402553,0.00004927252,0.000711414],"genre_scores_gemma":[0.9948967,0.0001918302,0.000197938,0.000079234,0.0001903405,0.001401071,0.0007243604,0.00007051534,0.002248019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02137805,"threshold_uncertainty_score":0.9911952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126709547","doi":"10.1158/1078-0432.ccr-11-3090","title":"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Medicine; Internal medicine; Oncology; Biomarker; Toxicity; Phases of clinical research; Clinical endpoint; Lung cancer; Clinical trial; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1977189728280281,"gpt":0.5160958239841599,"spread":0.3183768511561318,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003314531,0.0002812326,0.0008747581,0.0003912191,0.0002402557,0.00002482082,0.000268043,0.0001895922,0.0002439453],"category_scores_gemma":[0.0008549059,0.0002003439,0.00008864985,0.001049968,0.0008143578,0.0001666914,0.0007010311,0.001386093,0.000006023385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007937654,"about_ca_system_score_gemma":0.0006288863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002941913,"about_ca_topic_score_gemma":0.001326184,"domain_scores_codex":[0.9948379,0.0007551244,0.0009432678,0.000720286,0.001572675,0.001170746],"domain_scores_gemma":[0.9964734,0.001131271,0.0001937432,0.0006253099,0.0009253419,0.0006508805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009951431,0.01845595,0.9496948,0.0005030707,0.0003830563,0.00002586403,0.00261672,0.000003619044,0.0004238939,0.000002335329,0.00350294,0.01443634],"study_design_scores_gemma":[0.04807788,0.02172265,0.9253666,0.0009142729,0.0002231519,8.018309e-7,0.001252373,0.0001285612,0.0005274646,0.000005671146,0.001510517,0.0002700842],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855751,0.009300147,0.000002127036,0.0005585026,0.0003725081,0.003621952,0.00004221023,0.00002624023,0.0005012303],"genre_scores_gemma":[0.9965475,0.001330977,0.00005051981,0.00007668811,0.0002454726,0.0007587486,0.00001272997,0.00006357252,0.0009138071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03812645,"threshold_uncertainty_score":0.8169787,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168572010","doi":"10.1158/1078-0432.ccr-12-0234","title":"CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Antigen; CD20; Biology; CD8; Immunology; Tumor-infiltrating lymphocytes; Ovarian cancer; CD5; Cancer research; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1497475166899614,"gpt":0.4592862070979238,"spread":0.3095386904079623,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044572,0.0002757619,0.0006364384,0.0001836206,0.00021645,0.00009127123,0.0002371955,0.0002587891,0.00110497],"category_scores_gemma":[0.0002170666,0.0002019209,0.0001016763,0.0006107337,0.0008815475,0.0003304329,0.0001157011,0.001122718,0.00001754699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005120459,"about_ca_system_score_gemma":0.001442585,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00964436,"about_ca_topic_score_gemma":0.004591089,"domain_scores_codex":[0.9959648,0.0006402156,0.000715738,0.0007131567,0.0008255224,0.001140595],"domain_scores_gemma":[0.9979576,0.0005013389,0.0001344331,0.0004694541,0.0003239501,0.0006132109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02270953,0.001197764,0.8539962,0.0003640946,0.0002746729,0.00007942126,0.002198679,0.000007919507,0.03142251,0.00003387288,0.0007954597,0.08691993],"study_design_scores_gemma":[0.01867274,0.00595563,0.8619871,0.00216193,0.0002008848,0.00007419621,0.002489716,0.0009659861,0.08959229,0.0001135576,0.01682376,0.0009621785],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886748,0.006374221,0.000008128084,0.001893439,0.0002515173,0.001440256,0.00002265126,0.00004510469,0.001289945],"genre_scores_gemma":[0.9941526,0.001433185,0.001035533,0.0008222764,0.001085465,0.0005476347,0.000008539075,0.00007778152,0.0008369811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08595774,"threshold_uncertainty_score":0.9998081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162630386","doi":"10.1158/1078-0432.ccr-05-0464","title":"Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":541,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"Jonsson Cancer Center Foundation; National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Immune system; Dendritic cell; Cytotoxic T cell; Adverse effect; Vaccination; Immunotherapy; Tumor microenvironment; CTL*; T cell; Immunology; Pathology; CD8; Cancer research; Internal medicine; Biology; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.02518037491735347,"gpt":0.3300917701125096,"spread":0.3049113951951561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022343,0.000234878,0.0004201613,0.0001840494,0.0003899302,0.00005911208,0.0004765067,0.0003461786,0.0001674371],"category_scores_gemma":[0.0001776881,0.0001758929,0.00009422935,0.0002714075,0.0005779791,0.0001378088,0.0001911261,0.001263765,0.0001775894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005897144,"about_ca_system_score_gemma":0.0002090243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000557958,"about_ca_topic_score_gemma":0.0001311066,"domain_scores_codex":[0.9935746,0.003905789,0.0009231233,0.000538162,0.0001894965,0.0008687964],"domain_scores_gemma":[0.9977257,0.001547365,0.0001688173,0.0003794102,0.0001177868,0.0000609575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02477579,0.002350019,0.02680989,0.0003736606,0.0001650118,0.00005263548,0.001431558,0.0001210893,0.744018,0.00002064048,0.005856672,0.1940251],"study_design_scores_gemma":[0.02113769,0.003923181,0.5897487,0.0007444508,0.00008107798,0.0002127387,0.004143278,0.0005444178,0.3530388,0.00001239975,0.02560813,0.0008051698],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9719561,0.02598765,0.00001896305,0.0005179329,0.0005001372,0.0008837241,0.00006546004,0.00003309261,0.00003695253],"genre_scores_gemma":[0.9967663,0.001457976,0.000005356414,0.0001347923,0.00007984099,0.0001470935,0.00001842352,0.00003426797,0.001355939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5629388,"threshold_uncertainty_score":0.7172705,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2884100356","doi":"10.1158/1078-0432.ccr-18-1481","title":"Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":523,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of Victoria","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Networks of Centres of Excellence of Canada; Michael Smith Health Research BC","keywords":"Cancer; Tumor cells; Cancer research; Medicine; Pathology; Human plasma; Cancer cell; Biology; Internal medicine; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.3274036531060941,"gpt":0.5512920413785712,"spread":0.2238883882724771,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005096012,0.0004588871,0.002781218,0.0004669187,0.0001446847,0.00005287078,0.0004987658,0.0005542781,0.0007304748],"category_scores_gemma":[0.0004667347,0.0003581831,0.0005424988,0.001242131,0.002023897,0.00006296892,0.0002205225,0.002269801,0.00002232341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004908446,"about_ca_system_score_gemma":0.0033836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002894978,"about_ca_topic_score_gemma":0.00114864,"domain_scores_codex":[0.9935822,0.001119301,0.002343433,0.001140224,0.0009396507,0.0008751816],"domain_scores_gemma":[0.9949513,0.002871154,0.0006687635,0.0007286244,0.000450613,0.0003295083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001127916,0.0005251243,0.004219884,0.05519702,0.0005757733,0.0001438718,0.0001547237,5.617988e-7,0.001860205,0.00001189759,0.008855876,0.9273272],"study_design_scores_gemma":[0.002396145,0.001668178,0.0007901482,0.06416312,0.0004474652,0.00001336842,0.00006858286,0.0000176607,0.001698837,0.00002195582,0.9282327,0.0004818173],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02301401,0.9719826,8.549895e-7,0.00009712668,0.0005952657,0.003367082,0.000253041,0.00002475263,0.0006652402],"genre_scores_gemma":[0.003221578,0.9929717,0.0001078148,0.00008071696,0.001142601,0.001127992,0.00002097619,0.0001043027,0.001222352],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9268453,"threshold_uncertainty_score":0.999887,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2620901258","doi":"10.1158/1078-0432.ccr-17-0408","title":"Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":521,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Institute for Health and Care Research","keywords":"Li–Fraumeni syndrome; Medicine; Psychosocial; Cancer; Germline; Germline mutation; Pediatric cancer; Oncology; Internal medicine; Mutation; Gene; Genetics; Psychiatry; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.7166226886873909,"gpt":0.659810640990961,"spread":0.05681204769642989,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004785682,0.0006274711,0.00350187,0.0006402525,0.0007547497,0.000224997,0.001032009,0.001053662,0.0009929087],"category_scores_gemma":[0.001466436,0.0004363679,0.0008897491,0.0008294027,0.0009705205,0.0001416382,0.0004112441,0.004463636,0.00009091689],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008633339,"about_ca_system_score_gemma":0.008650294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000711845,"about_ca_topic_score_gemma":0.0006600876,"domain_scores_codex":[0.993414,0.0007308216,0.001508995,0.001590391,0.001455889,0.001299885],"domain_scores_gemma":[0.9926839,0.002416732,0.0008791134,0.002052288,0.001150892,0.0008170914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003292229,0.0001671008,0.0002524318,0.008354612,0.002218648,0.0001732951,0.00002496527,0.000002250723,1.263017e-7,0.00003281098,0.033121,0.9553235],"study_design_scores_gemma":[0.003081527,0.001947675,0.00009168623,0.07327247,0.002335346,0.0001937551,0.00001907729,0.000008331047,0.000001673097,0.00002090293,0.9185473,0.000480236],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003355614,0.9846251,0.0004581072,0.005047883,0.0005782119,0.006820696,0.001429782,0.00009251996,0.0009141643],"genre_scores_gemma":[0.00002353685,0.9767385,0.003932413,0.0002238557,0.001282372,0.01050338,0.0006526462,0.000327216,0.006316052],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9548433,"threshold_uncertainty_score":0.9999203,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2080518844","doi":"10.1158/1078-0432.ccr-07-0701","title":"Human Breast Cancer Cells Selected for Resistance to Trastuzumab <i>In vivo</i> Overexpress Epidermal Growth Factor Receptor and ErbB Ligands and Remain Dependent on the ErbB Receptor Network","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":506,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Trastuzumab; Gefitinib; Lapatinib; Erlotinib; Cancer research; Epidermal growth factor receptor; ErbB; In vivo; Epidermal growth factor; Growth factor receptor; Biology; Cancer; Receptor; Medicine; Breast cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1265625171483836,"gpt":0.4760326595411657,"spread":0.3494701423927821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01124786,0.000445604,0.001004069,0.0003155386,0.0006452368,0.0001664,0.0006203715,0.0004904439,0.001226262],"category_scores_gemma":[0.002103018,0.0003362303,0.0001596851,0.001564214,0.0008341739,0.000116961,0.0003695892,0.002620024,0.00002278211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001289594,"about_ca_system_score_gemma":0.00115486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001451196,"about_ca_topic_score_gemma":0.009862454,"domain_scores_codex":[0.9920809,0.0008688256,0.001343812,0.001578211,0.001899071,0.002229211],"domain_scores_gemma":[0.9904063,0.006104253,0.0001742863,0.0008250521,0.001234011,0.001256091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.03018586,0.0009955278,0.1269149,0.001511749,0.0003720135,0.0001028863,0.001413442,0.00003039662,0.1842761,0.001163258,0.6370759,0.01595803],"study_design_scores_gemma":[0.01800708,0.006794556,0.4895768,0.008240636,0.0001317124,0.00002860109,0.001161182,0.0001581859,0.2839026,0.001013483,0.1890868,0.001898459],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713251,0.001997479,0.00005551491,0.01990088,0.0005317498,0.00446675,0.0008663795,0.00006621258,0.0007899441],"genre_scores_gemma":[0.9820852,0.003660092,0.0005469645,0.002388969,0.003466727,0.0008554432,0.00001442688,0.0001683567,0.00681379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4479891,"threshold_uncertainty_score":0.999909,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093916414","doi":"10.1158/1078-0432.ccr-05-1664","title":"The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":496,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Doxorubicin; Distribution (mathematics); Hypoxia (environmental); Pathology; Cancer research; Medicine; Biology; Chemistry; Chemotherapy; Internal medicine; Oxygen","retraction":null,"screen_n_in":null,"score":{"opus":0.09744040762682671,"gpt":0.4903308333198168,"spread":0.3928904256929901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004556104,0.0000764946,0.0002699868,0.00007024501,0.0001024836,0.00001553824,0.0001989461,0.0001100289,0.0000282179],"category_scores_gemma":[0.001657895,0.00004793662,0.0001072722,0.0009618414,0.00030178,0.00006204199,0.00007497643,0.0009459929,0.000009718266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003399726,"about_ca_system_score_gemma":0.0004708976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005377237,"about_ca_topic_score_gemma":0.001900579,"domain_scores_codex":[0.9976487,0.0004803626,0.0006388307,0.0002606408,0.0006342876,0.0003371913],"domain_scores_gemma":[0.998346,0.0008672589,0.00007710093,0.0003938766,0.0002194752,0.00009624667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002513083,0.001083439,0.6960762,0.0001515563,0.0001042437,0.00001418789,0.002340726,0.001544821,0.150476,0.001751835,0.005003258,0.1389407],"study_design_scores_gemma":[0.001813205,0.0001180939,0.8171142,0.0004952135,0.00001291304,0.000001808042,0.0001864624,0.0003856265,0.1761739,0.000432999,0.00320633,0.00005926536],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9721594,0.0003928359,0.00001123405,0.02601632,0.0001079403,0.0008310883,0.00001020101,0.000007304641,0.00046365],"genre_scores_gemma":[0.9979335,0.0007477116,0.00001405732,0.0003819969,0.0003951725,0.0001007937,0.00000606416,0.00001143807,0.0004092567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1388814,"threshold_uncertainty_score":0.4109921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144247813","doi":"10.1158/1078-0432.ccr-08-2132","title":"Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":485,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Oncology; Medicine; Basal (medicine); Immunohistochemistry; Internal medicine; Progesterone receptor; Estrogen receptor; Cancer; Metastasis; Pathology; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.1206795912133779,"gpt":0.4911984173744459,"spread":0.370518826161068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001123944,0.0002105298,0.0003823178,0.00005915149,0.0003341975,0.00006845011,0.0002889021,0.0002047455,0.00006320781],"category_scores_gemma":[0.0008171642,0.0001794788,0.0001118802,0.0002459966,0.0006078421,0.000009964964,0.0002711477,0.0005142699,0.000008668777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009443064,"about_ca_system_score_gemma":0.0003517287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001855617,"about_ca_topic_score_gemma":0.0008983714,"domain_scores_codex":[0.9974934,0.0003503382,0.0003941077,0.0007609818,0.0004002333,0.0006008823],"domain_scores_gemma":[0.9984778,0.0004163117,0.00009368967,0.0003352384,0.0004094202,0.0002675884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001116139,0.0001431893,0.851155,0.00002795919,0.0002567801,0.00001191277,0.0001247428,0.000002859359,0.0008658174,0.00005760774,0.01195992,0.1342781],"study_design_scores_gemma":[0.001768493,0.0004004258,0.9901189,0.00008187468,0.00004570494,0.000003219386,0.00009134715,0.000008112544,0.002428975,0.0007012198,0.00412737,0.0002243459],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830617,0.003639355,0.0000273556,0.01096472,0.0002816027,0.0003641635,0.0004936293,0.00002560327,0.001141844],"genre_scores_gemma":[0.9921142,0.003610769,0.0001472967,0.0004705981,0.00311696,0.00009680333,0.00003653218,0.00002570048,0.0003811087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1389639,"threshold_uncertainty_score":0.7318931,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160463964","doi":"10.1158/1078-0432.ccr-14-2666","title":"Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":479,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Androgen receptor; Medicine; Cancer research; Prostate; Androgen; Cancer; Castration; Oncology; Internal medicine; Hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.2777102049017103,"gpt":0.5002984513579463,"spread":0.222588246456236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004228184,0.0001974184,0.000585645,0.0004622063,0.0001034013,0.00003948536,0.0003325237,0.0002100153,0.0001916445],"category_scores_gemma":[0.0007756774,0.0001639863,0.0001214219,0.001795161,0.0006281409,0.0001536604,0.0001435307,0.0008565205,0.00001311807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001139066,"about_ca_system_score_gemma":0.004186588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003593834,"about_ca_topic_score_gemma":0.01652407,"domain_scores_codex":[0.9954748,0.0007270283,0.001124717,0.000655677,0.001230098,0.0007876492],"domain_scores_gemma":[0.9973515,0.000504287,0.0001681909,0.0006746516,0.0008880203,0.0004133279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01428895,0.001833126,0.8154408,0.0009077794,0.0003675577,0.0003759279,0.004047058,0.0001570214,0.1394646,0.0001951983,0.0119436,0.01097838],"study_design_scores_gemma":[0.06073011,0.003344798,0.8007284,0.003730774,0.0001832958,0.000008164749,0.00628937,0.001028038,0.1029055,0.005629691,0.01431948,0.001102365],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663246,0.02184895,0.000002486555,0.006688684,0.0002060982,0.001764397,0.0001596452,0.00002055129,0.002984639],"genre_scores_gemma":[0.9910774,0.004731101,0.0004935679,0.00007491542,0.0001885431,0.000828277,0.00005086812,0.00004429282,0.002511033],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04644116,"threshold_uncertainty_score":0.9220818,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129567747","doi":"10.1158/1078-0432.ccr-09-2824","title":"Cancer Stem Cells and Self-renewal","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":474,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cancer; Cancer stem cell; Context (archaeology); Stem cell; Cancer cell; Biology; Cancer research; Confusion; Neuroscience; Cell biology; Psychology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.4688566519017544,"gpt":0.611672748125227,"spread":0.1428160962234726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003921059,0.0005092599,0.003286258,0.0003404347,0.0001922073,0.0001038697,0.0004570511,0.001162558,0.001682276],"category_scores_gemma":[0.0001217512,0.000364089,0.000896694,0.0007873966,0.0008829652,0.00004921092,0.0005018241,0.00530455,0.0002162382],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004534347,"about_ca_system_score_gemma":0.005848042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001436488,"about_ca_topic_score_gemma":0.0009156,"domain_scores_codex":[0.9942836,0.0007679932,0.001396112,0.001352813,0.00117734,0.0010222],"domain_scores_gemma":[0.9954299,0.001491582,0.0003054376,0.001079227,0.0005427154,0.001151139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007995879,0.0002574254,0.00008801612,0.01746548,0.0004489498,0.00007873421,0.00002556025,2.918818e-8,0.000004945597,0.00002802611,0.01556711,0.9659558],"study_design_scores_gemma":[0.0009672545,0.0003347203,0.00001068529,0.009088081,0.001691516,0.00002503956,0.00001284535,0.000001125087,0.00003500788,0.00001830463,0.9874794,0.0003360365],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002873834,0.992566,9.564827e-7,0.0005143157,0.002199485,0.002004083,0.0003647383,0.00007421761,0.001988791],"genre_scores_gemma":[0.00001899104,0.9822752,0.0001706786,0.0002029787,0.00444952,0.001075202,0.00002065718,0.0001542414,0.01163246],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9719123,"threshold_uncertainty_score":0.9998811,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141410122","doi":"10.1158/1078-0432.ccr-07-0674","title":"Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Chimeric antigen receptor; Immunology; Adoptive cell transfer; Cancer research; T cell; Homing (biology); Medicine; Ex vivo; Systemic administration; CD28; Immunotherapy; Leukemia; In vivo; Biology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.1267420617162681,"gpt":0.4841363589671988,"spread":0.3573942972509307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01182176,0.0003477754,0.0009728475,0.0006329559,0.0002935792,0.0001070407,0.000848869,0.0006184974,0.007633899],"category_scores_gemma":[0.001101835,0.0002931771,0.0004673704,0.00177066,0.001643009,0.00007517867,0.0004421939,0.002738963,0.00165706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002058638,"about_ca_system_score_gemma":0.003537073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004197487,"about_ca_topic_score_gemma":0.0001091606,"domain_scores_codex":[0.9911961,0.0008524598,0.001573085,0.001216313,0.002904716,0.002257342],"domain_scores_gemma":[0.9919121,0.003335268,0.000137338,0.00138642,0.001338551,0.001890336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01101208,0.0006246184,0.02477793,0.000497378,0.001019823,0.002137868,0.0002098579,0.00003249083,0.8142546,0.0001365388,0.03509162,0.1102052],"study_design_scores_gemma":[0.03181124,0.0116791,0.1960239,0.002382375,0.0008267016,0.0009118053,0.0005273339,0.004486745,0.3772839,0.0007110121,0.3713591,0.001996801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845899,0.003192235,0.0006132639,0.00129638,0.001121613,0.001945578,0.00004053016,0.0001784249,0.007022093],"genre_scores_gemma":[0.9621128,0.007220078,0.0006776449,0.000808335,0.003151006,0.0001939287,0.0000310269,0.0001602522,0.02564496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4369707,"threshold_uncertainty_score":0.999952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106381426","doi":"10.1158/1078-0432.ccr-05-2290","title":"Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":461,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"LNCaP; Medicine; Prostate cancer; Prostate-specific antigen; Gallic acid; Nitric oxide; Lipid peroxidation; Apoptosis; Internal medicine; Prostate; Gastroenterology; Cancer; Urology; Antioxidant; Endocrinology; Oxidative stress; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.242046693455873,"gpt":0.5389426306171787,"spread":0.2968959371613057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.004895208,0.0002514935,0.0008355379,0.0004861804,0.00149444,0.0001128725,0.0002646285,0.0001473797,0.00003003918],"category_scores_gemma":[0.000267445,0.0001948075,0.0002459077,0.001149679,0.0001797573,0.0002925841,0.00005985131,0.0004650303,0.000001512163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004039485,"about_ca_system_score_gemma":0.0008299981,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0084606,"about_ca_topic_score_gemma":0.00616868,"domain_scores_codex":[0.9954218,0.0004486974,0.001407587,0.0008159428,0.0008133426,0.001092641],"domain_scores_gemma":[0.994378,0.003546835,0.0003980038,0.0004327368,0.001014173,0.0002302006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1609413,0.01717771,0.1183263,0.002010729,0.000641579,0.00006591475,0.005009574,0.001588927,0.005624997,0.0001304573,0.07159032,0.6168922],"study_design_scores_gemma":[0.2074456,0.1482998,0.3211232,0.006685676,0.001118937,0.000008181903,0.009344407,0.01964664,0.02487133,0.00369912,0.2540681,0.003688957],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859735,0.003414024,0.0001176348,0.002571655,0.0007037454,0.006565414,0.0005126565,0.00006271665,0.00007865627],"genre_scores_gemma":[0.9944714,0.000991322,0.0004240246,0.00008100399,0.0006963387,0.002674156,0.0001074233,0.00009587055,0.0004584815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6132032,"threshold_uncertainty_score":0.9998055,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049601932","doi":"10.1158/1078-0432.ccr-13-0545","title":"Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":451,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CTLA-4; Medicine; Pharmacology; Immunology; Cancer research; Immune system; T cell","retraction":null,"screen_n_in":null,"score":{"opus":0.09677112979043904,"gpt":0.4552541279929487,"spread":0.3584829982025097,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001600728,0.00009905105,0.0002161957,0.00003093306,0.0001749913,0.00004073217,0.0002865217,0.0001276493,0.0002224922],"category_scores_gemma":[0.0004286814,0.00006573006,0.00007485243,0.0001366606,0.0005916551,0.000009718762,0.0003120471,0.0003589211,0.00001606976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005746193,"about_ca_system_score_gemma":0.0001467897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006194016,"about_ca_topic_score_gemma":0.000008199743,"domain_scores_codex":[0.9983853,0.0003572637,0.0003026205,0.0003599424,0.0002682366,0.000326634],"domain_scores_gemma":[0.9989353,0.0002934829,0.00009817139,0.0002867737,0.0002918908,0.00009437206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006082774,0.00007855242,0.04130513,0.00004969023,0.00005940394,0.000002329201,0.00002507137,0.00002363066,0.9345482,0.00002636477,0.02073754,0.003083249],"study_design_scores_gemma":[0.0007028026,0.0004237218,0.1113612,0.00006632739,0.00002068497,0.000004458892,0.0001797341,0.0003330624,0.8711779,0.0001814047,0.01532579,0.0002229751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927225,0.005136814,0.0001131511,0.001297927,0.0001276157,0.0002522501,0.000008578231,0.000005023253,0.0003362153],"genre_scores_gemma":[0.9934437,0.005224481,0.00007939442,0.0001159281,0.0006915411,0.00004233493,0.0000063552,0.00001373078,0.0003825066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07005605,"threshold_uncertainty_score":0.2680394,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010399667","doi":"10.1158/1078-0432.ccr-07-4879","title":"The Type 1 Insulin-Like Growth Factor Receptor Pathway","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Cancer Research UK; Wellcome Trust","keywords":"Insulin-like growth factor 1 receptor; Insulin receptor; Insulin-like growth factor; Receptor tyrosine kinase; Medicine; Targeted therapy; Tyrosine kinase; Insulin-Like Growth Factor Receptor; Receptor; Signal transduction; Cancer; Pharmacology; Cancer research; Insulin; Biology; Insulin resistance; Growth factor; Internal medicine; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.389277735689035,"gpt":0.5307568062604718,"spread":0.1414790705714369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003246713,0.0008547772,0.003512173,0.0004681713,0.0009981458,0.0001508445,0.00154132,0.001724877,0.0007857124],"category_scores_gemma":[0.00812972,0.0004900416,0.001792612,0.002628106,0.001848083,0.0001325243,0.0007269779,0.007988887,0.003960705],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008319237,"about_ca_system_score_gemma":0.008481524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002485955,"about_ca_topic_score_gemma":0.00002766468,"domain_scores_codex":[0.9890295,0.002407109,0.002813513,0.001547077,0.002406802,0.001795968],"domain_scores_gemma":[0.9881519,0.005941994,0.0005547378,0.001920044,0.002152027,0.001279299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000386158,0.000279196,0.0004346757,0.002990542,0.0005216436,0.0001031584,0.00005188904,6.028018e-9,0.000001146614,0.0001145123,0.1788397,0.8162774],"study_design_scores_gemma":[0.0009229864,0.001348028,0.0005441274,0.004434522,0.0001880116,0.00004851364,0.00002478947,0.000001090645,0.000005044319,0.00005057494,0.9919327,0.0004995403],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005290661,0.9883097,0.000001178542,0.0008055926,0.004141718,0.00271848,0.000213382,0.000148725,0.003132107],"genre_scores_gemma":[0.0001527546,0.9840028,0.00004934909,0.000372778,0.004371014,0.0005662689,0.000221861,0.0002698736,0.0099933],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8157779,"threshold_uncertainty_score":0.9997551,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122664628","doi":"10.1158/1078-0432.ccr-04-0684","title":"Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":444,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"Ligue Contre le Cancer","keywords":"Breast cancer; Infiltration (HVAC); Stage (stratigraphy); Medicine; Cancer; Pathology; Oncology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1111173451219429,"gpt":0.4492887814914478,"spread":0.3381714363695049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001339539,0.0001169806,0.0003046388,0.0001319567,0.0001997799,0.00002518722,0.0002324216,0.0002743232,0.001032512],"category_scores_gemma":[0.0001313112,0.00009926555,0.00009146142,0.0002656273,0.00111281,0.0001313515,0.00009490765,0.000739933,0.00006698404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006741207,"about_ca_system_score_gemma":0.0006062349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0051284,"about_ca_topic_score_gemma":0.0002368199,"domain_scores_codex":[0.9979851,0.0006689708,0.0005058692,0.0003096697,0.0001042772,0.0004261215],"domain_scores_gemma":[0.9986759,0.0006203152,0.0001022237,0.0002465507,0.0003186413,0.00003639443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006345563,0.0009798238,0.2606269,0.000238196,0.0003288802,0.000008736411,0.001158123,0.00001603213,0.672155,0.0009023038,0.0007984651,0.05644197],"study_design_scores_gemma":[0.004780529,0.001345648,0.6635023,0.0002644082,0.00003206439,0.00001328056,0.0003208371,8.444701e-7,0.3167507,0.000240901,0.01253728,0.0002111025],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790477,0.0187435,0.00001391972,0.001128746,0.0003315764,0.0003660131,0.0001263412,0.00002062992,0.0002215335],"genre_scores_gemma":[0.9858927,0.01115332,0.00002351611,0.00009210531,0.00005545191,0.0001440347,0.000008066256,0.00001827505,0.002612592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4028754,"threshold_uncertainty_score":0.9998807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136226205","doi":"10.1158/1078-0432.ccr-05-0343","title":"Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":440,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Doxorubicin; Bioavailability; Pharmacokinetics; Pharmacology; Liposome; In vivo; Medicine; Drug; Chemistry; Chemotherapy; Internal medicine; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.1119151561545929,"gpt":0.4485344694636297,"spread":0.3366193133090368,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005159694,0.0001513022,0.0004711469,0.0003358541,0.00006302787,0.00005242438,0.0004006522,0.00007260424,0.001025968],"category_scores_gemma":[0.0005968648,0.000139183,0.00005057758,0.0007439262,0.0006734101,0.0003758923,0.0002960323,0.0005419688,0.00009338035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003969693,"about_ca_system_score_gemma":0.0005778442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004763519,"about_ca_topic_score_gemma":0.0096666,"domain_scores_codex":[0.9962276,0.000697943,0.001048092,0.0006154545,0.0007216297,0.0006893395],"domain_scores_gemma":[0.9980958,0.0008772457,0.0001624286,0.0003606441,0.0002900342,0.000213895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0009678773,0.0009606165,0.2495812,0.0002038677,0.00000387567,0.0001608335,0.0003984412,0.0004388912,0.6985268,0.00008294688,0.000537509,0.04813717],"study_design_scores_gemma":[0.003030555,0.0002157666,0.7046589,0.0005753632,0.000006395473,0.00001320415,0.0001711047,0.00547525,0.2848583,0.0002468553,0.0005145769,0.0002337339],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951082,0.0004887563,0.000004398403,0.003554489,0.0001322266,0.0004542568,0.000169505,0.00002031977,0.00006784148],"genre_scores_gemma":[0.9986772,0.00007049236,0.0003917516,0.0002617431,0.0002546386,0.0001625843,0.000001202307,0.00002673131,0.0001536401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4550778,"threshold_uncertainty_score":0.9998872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019458473","doi":"10.1158/1078-0432.ccr-10-1533","title":"Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":435,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Medicine; Estrogen receptor; Internal medicine; Oncology; Cancer; Basal (medicine); Population; Estrogen; Breast disease; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.0692084032633277,"gpt":0.4515455146438874,"spread":0.3823371113805597,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002592045,0.000236893,0.0003926696,0.00008298755,0.0002533175,0.00007108449,0.0005671293,0.0001608199,0.0001185205],"category_scores_gemma":[0.0002070569,0.000163025,0.00009369008,0.0003686209,0.0008164817,0.000009763729,0.0005456788,0.001116682,0.00001289718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005559632,"about_ca_system_score_gemma":0.0004580783,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004137085,"about_ca_topic_score_gemma":0.0658988,"domain_scores_codex":[0.9968346,0.0007458346,0.0004317393,0.0008184557,0.0005448412,0.0006244863],"domain_scores_gemma":[0.9982989,0.0003372995,0.00008193286,0.0007209514,0.0003868009,0.000174062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001053825,0.0007201382,0.9695534,0.00002547041,0.0001444866,0.00006145488,0.0001830615,8.319299e-7,0.0006178263,0.00001905237,0.0008182155,0.02680228],"study_design_scores_gemma":[0.00235755,0.0002540698,0.9956328,0.00002641743,0.00004032278,0.00007891283,0.0002976091,0.000001493534,0.00009885001,0.00002457893,0.001006243,0.0001811968],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917651,0.001924098,7.096491e-7,0.004573497,0.0005758349,0.000776974,0.0002060087,0.00001039757,0.0001673568],"genre_scores_gemma":[0.9951776,0.00201833,0.000005915253,0.0002346604,0.001774952,0.0005906528,0.00001929932,0.00003455863,0.0001440408],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06176171,"threshold_uncertainty_score":0.9511461,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106728539","doi":"10.1158/1078-0432.ccr-11-3216","title":"The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":434,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Value (mathematics); Cancer; Medicine; Pathology; Oncology; Internal medicine; Statistics","retraction":null,"screen_n_in":null,"score":{"opus":0.3397851811151872,"gpt":0.5872416934896351,"spread":0.2474565123744479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01146228,0.0003660083,0.002567711,0.0001467953,0.000180082,0.00003921251,0.001012844,0.0004169836,0.0002463584],"category_scores_gemma":[0.01083261,0.0001718621,0.001403853,0.002417007,0.002096822,0.00006200011,0.0003273293,0.002691815,0.000005000436],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006225743,"about_ca_system_score_gemma":0.006947468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006985194,"about_ca_topic_score_gemma":0.0001746719,"domain_scores_codex":[0.991286,0.003209364,0.002731204,0.0005430524,0.001404513,0.0008258505],"domain_scores_gemma":[0.9848613,0.01210791,0.0006677411,0.001222291,0.0009370768,0.0002037064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003423289,0.0002099471,0.002513969,0.232087,0.0002540766,0.00001164234,0.0000553208,3.128141e-8,0.000003185999,0.0001964035,0.002126372,0.7621998],"study_design_scores_gemma":[0.000484131,0.0002176609,0.001049396,0.4312887,0.0005413017,0.00003103842,0.00001776382,0.000002001303,0.00001018938,0.00003136745,0.5662068,0.0001196485],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002280381,0.9926517,2.00352e-7,0.002521276,0.0008224528,0.003222952,0.0001578754,0.000009479122,0.0003860208],"genre_scores_gemma":[0.0006705052,0.9961792,0.00002638927,0.0005000614,0.0009267976,0.001361241,0.00001364216,0.00006132678,0.0002607964],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7620801,"threshold_uncertainty_score":0.999609,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131555383","doi":"10.1158/1078-0432.ccr-04-0224","title":"The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":425,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Adenocarcinoma; Nucleoside analogue; Immunohistochemistry; Medicine; Nucleoside transporter; Internal medicine; Oncology; Chemotherapy; Nucleoside; Cancer; Pathology; Cancer research; Gastroenterology; Biology; Transporter","retraction":null,"screen_n_in":null,"score":{"opus":0.06715783176234653,"gpt":0.3910521475534355,"spread":0.323894315791089,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000888333,0.0001471518,0.0002746513,0.00004369385,0.0001435595,0.00002130067,0.0003283645,0.0001581812,0.00003545627],"category_scores_gemma":[0.0001319101,0.00009026466,0.00006676433,0.0003724062,0.0006038671,0.000009276426,0.00006506736,0.0004034909,0.000001453811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004593565,"about_ca_system_score_gemma":0.0003363734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007955767,"about_ca_topic_score_gemma":0.0007958033,"domain_scores_codex":[0.9979188,0.0002952049,0.0004391648,0.0004347088,0.0004905972,0.0004214878],"domain_scores_gemma":[0.9987423,0.0001711869,0.0001310052,0.0003574943,0.000487394,0.0001105558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002163768,0.0002960472,0.989722,0.00001038181,0.0001917234,0.00001474286,0.0001463663,0.00005387404,0.006903121,0.00006253567,0.0003204955,0.0001149899],"study_design_scores_gemma":[0.004163974,0.002374351,0.9709043,0.0001595378,0.00001929735,3.239722e-7,0.0001139681,0.000003699082,0.02192826,0.0001170961,0.00006048481,0.0001547206],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983968,0.0005712774,0.000009537143,0.000299124,0.00002545536,0.0003529353,0.00003828479,0.0000061045,0.0003005263],"genre_scores_gemma":[0.9993653,0.0001035812,0.00001951231,0.00005859277,0.00009285618,0.00004598975,0.00007438023,0.00002875137,0.000211065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01881767,"threshold_uncertainty_score":0.3680886,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2115999357","doi":"10.1158/1078-0432.ccr-11-2599","title":"Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":421,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Oncology; Estrogen receptor; Medicine; Internal medicine; Young adult; Gene expression profiling; Proportional hazards model; Cancer; Adjuvant; Gene expression; Biology; Cancer research; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.2104781409449193,"gpt":0.5165689887103124,"spread":0.3060908477653931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001775199,0.0001409796,0.0003156023,0.00009503579,0.0001286385,0.00001293574,0.0001413628,0.0001928869,0.00003138441],"category_scores_gemma":[0.00024287,0.0001197854,0.00004944616,0.0002335911,0.0004074862,0.00001424705,0.0004564987,0.0002905469,6.602105e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001509593,"about_ca_system_score_gemma":0.0002075695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001555701,"about_ca_topic_score_gemma":0.0001840367,"domain_scores_codex":[0.9978674,0.0003853359,0.0004529269,0.0004429342,0.0001655891,0.0006857922],"domain_scores_gemma":[0.9991619,0.0001330287,0.0001305582,0.0002164116,0.0002089198,0.0001491781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002491991,0.0001123328,0.6828215,0.00004458101,0.00004673393,3.453174e-7,0.0001979711,0.000009138495,0.3081184,0.000004959645,0.00001333259,0.008381476],"study_design_scores_gemma":[0.001239143,0.0001298116,0.6314589,0.0002319484,0.0000180844,0.000009401028,0.0006654082,0.00006448018,0.3658324,0.00004930946,0.0001090908,0.000192064],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916084,0.007550309,0.00007354495,0.0001570002,0.0001843603,0.0002845374,0.00007674211,0.000005554237,0.00005959228],"genre_scores_gemma":[0.9948168,0.002666869,0.001451114,0.00002635257,0.0006930137,0.0002963141,0.00001296291,0.00002491101,0.00001170479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05771395,"threshold_uncertainty_score":0.4884707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011143480","doi":"10.1158/1078-0432.ccr-09-1438","title":"Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institutes of Health; Gary Bennett Family Fund; National Cancer Institute; Entertainment Industry Foundation","keywords":"Microsatellite instability; Colorectal cancer; KRAS; MLH1; Oncology; Medicine; CDKN2A; Hazard ratio; Internal medicine; Cancer; Lymph node; Cancer research; Pathology; Biology; DNA mismatch repair; Genetics; Microsatellite; Allele","retraction":null,"screen_n_in":null,"score":{"opus":0.1168728710865077,"gpt":0.4473887609781676,"spread":0.3305158898916599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003088058,0.0002387063,0.0008673699,0.0001845678,0.0001391898,0.00005564126,0.0001958442,0.0003177735,0.0004778139],"category_scores_gemma":[0.000671687,0.0001835741,0.000127587,0.0009431056,0.0004628,0.0001089501,0.0001144925,0.0006162014,0.00001335793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001576371,"about_ca_system_score_gemma":0.002070262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004568136,"about_ca_topic_score_gemma":0.002307662,"domain_scores_codex":[0.9961037,0.0004114085,0.0007504037,0.0008005201,0.001308027,0.0006259558],"domain_scores_gemma":[0.9969373,0.0006593855,0.0001853436,0.0004077473,0.001335432,0.0004747871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0107476,0.0009610741,0.9177092,0.0002269897,0.0005151196,0.00002364507,0.0008616568,0.00001288173,0.02596215,0.00003130733,0.002317968,0.04063036],"study_design_scores_gemma":[0.00514848,0.002066262,0.9725421,0.0006138545,0.000189618,0.000003855796,0.0001792165,0.0001310814,0.01620119,0.00007866292,0.002591236,0.0002544583],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925923,0.002710474,0.00001133654,0.002603445,0.0002324777,0.000897648,0.0001885012,0.00003160269,0.0007322427],"genre_scores_gemma":[0.9934061,0.004564545,0.00005040977,0.001139911,0.0002463929,0.0002187359,0.00001667696,0.00003835679,0.0003188605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05483284,"threshold_uncertainty_score":0.7485933,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156375860","doi":"10.1158/1078-0432.ccr-13-1877","title":"Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"CD8; Tumor-infiltrating lymphocytes; Serous fluid; Cancer research; Ovarian cancer; Immunotherapy; Intraepithelial lymphocyte; Biology; Antigen; Pathology; Cancer; Immunology; Medicine; Immune system; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1177334348162059,"gpt":0.431224146604903,"spread":0.3134907117886971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005930807,0.0003164647,0.0007983103,0.0001967769,0.0004192299,0.0002293111,0.0004945842,0.0002608281,0.002554012],"category_scores_gemma":[0.001746983,0.0002010468,0.0001446163,0.001159402,0.0009435784,0.000217978,0.000171599,0.001512545,0.00002834289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001449783,"about_ca_system_score_gemma":0.002115585,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1600624,"about_ca_topic_score_gemma":0.02801445,"domain_scores_codex":[0.9935333,0.002114273,0.001027572,0.000773598,0.001495839,0.001055419],"domain_scores_gemma":[0.9948359,0.003055254,0.0003508541,0.000778399,0.0006409198,0.0003387016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007106677,0.0005089479,0.9308019,0.0001860065,0.0006224631,0.000387453,0.0006939349,0.00004782065,0.01356435,0.00001218278,0.01362852,0.03243978],"study_design_scores_gemma":[0.008617586,0.0004176127,0.9808018,0.002117947,0.00006029064,0.0000128117,0.001453753,0.0002739858,0.004511032,0.00007211429,0.001370862,0.0002902537],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850219,0.003393791,0.000004582746,0.008642268,0.0004156427,0.001638947,0.00003797458,0.00007235577,0.0007724721],"genre_scores_gemma":[0.993714,0.0009685653,0.00008524051,0.001492878,0.0007992478,0.00106205,0.00002081726,0.00008273074,0.001774494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1320479,"threshold_uncertainty_score":0.9983578,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105260398","doi":"10.1158/1078-0432.ccr-09-2166","title":"Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":396,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"microRNA; Head and neck squamous-cell carcinoma; Cancer research; Downregulation and upregulation; Cell cycle; Clonogenic assay; Gene knockdown; Biology; Cell growth; Flow cytometry; Cell; Cell culture; Cancer; Head and neck cancer; Molecular biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1134332804949355,"gpt":0.4556207139829654,"spread":0.3421874334880299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000631208,0.0001109034,0.0001640061,0.00004068914,0.0001543539,0.0000385021,0.0001989135,0.0002541873,0.00002794255],"category_scores_gemma":[0.0003753328,0.0001055442,0.0001024768,0.00007862372,0.0003747465,0.000003455846,0.000203635,0.0004105441,0.000008009154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001534036,"about_ca_system_score_gemma":0.0003061084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006768195,"about_ca_topic_score_gemma":0.0001305972,"domain_scores_codex":[0.9985092,0.0001326211,0.0002936583,0.0005231559,0.0001670726,0.0003743148],"domain_scores_gemma":[0.9986154,0.0002166605,0.00005914626,0.0003843179,0.0005063307,0.0002181298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004668146,0.00008858624,0.03823442,0.0001400071,0.00001272471,0.00000172275,0.00001144577,0.000004528774,0.9553799,0.00003771023,0.00333321,0.002288899],"study_design_scores_gemma":[0.003117206,0.0007732635,0.1109689,0.00001782609,0.00002138487,0.000005226578,0.00005043767,0.0002670449,0.7069325,0.0002832304,0.1772982,0.0002647488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955551,0.002694399,0.0000591529,0.0003689215,0.000282445,0.0007453975,0.00006929877,0.000008732382,0.0002165377],"genre_scores_gemma":[0.9963206,0.0001645471,0.001720099,0.0001477529,0.0009566038,0.0001536462,0.00008577651,0.00003047817,0.0004204763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2484474,"threshold_uncertainty_score":0.4303968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2964673115","doi":"10.1158/1078-0432.ccr-19-1423","title":"The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Prostate cancer; Lineage (genetic); Cancer; Resistance (ecology); Medicine; Cancer therapy; Biology; Internal medicine; Genetics; Ecology","retraction":null,"screen_n_in":null,"score":{"opus":0.1459517182911886,"gpt":0.5267830732056228,"spread":0.3808313549144342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002765472,0.0001542473,0.0005032504,0.0001508555,0.0001472059,0.00003697764,0.0003811175,0.0001340999,0.0004957248],"category_scores_gemma":[0.000512291,0.00008895103,0.0001537376,0.0008782211,0.0008610744,0.00007439348,0.0001582565,0.001372381,0.00006975241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003182284,"about_ca_system_score_gemma":0.001679179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001241506,"about_ca_topic_score_gemma":0.001863305,"domain_scores_codex":[0.9963215,0.0004928121,0.0007127125,0.0005243493,0.001133077,0.0008155328],"domain_scores_gemma":[0.9961531,0.002272468,0.0001127035,0.0005258939,0.0007047867,0.0002310204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01834038,0.000498871,0.9152297,0.0001732034,0.0001536367,0.00003481433,0.0003384478,0.00001412752,0.006227902,0.0003594833,0.002461525,0.05616791],"study_design_scores_gemma":[0.01337812,0.001852934,0.564806,0.00117773,0.00002118455,0.000001368284,0.0008698072,0.0004818909,0.06101418,0.001445308,0.3546897,0.0002617904],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9529132,0.0349048,2.946393e-7,0.004098847,0.0002164847,0.001834989,0.00005133885,0.00001804814,0.005961963],"genre_scores_gemma":[0.897692,0.07933275,0.00002202684,0.00008909259,0.0002612347,0.0005402646,0.000005844812,0.00003241904,0.02202436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3522281,"threshold_uncertainty_score":0.5962389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113325722","doi":"10.1158/1078-0432.ccr-11-1331","title":"Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":388,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Montreal General Hospital","funders":"","keywords":"Indoleamine 2,3-dioxygenase; Immune system; Medicine; Immunology; Immunotherapy; Cancer; Cancer immunotherapy; Clinical trial; Cancer research; Tryptophan Metabolism; Biology; Internal medicine; Tryptophan","retraction":null,"screen_n_in":null,"score":{"opus":0.5876062187741322,"gpt":0.5994187160481229,"spread":0.0118124972739907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005184193,0.0005270166,0.002383476,0.0006197078,0.0003255217,0.0001162967,0.001498856,0.001133658,0.0007925758],"category_scores_gemma":[0.008313728,0.0003919663,0.0005617375,0.001317762,0.004032087,0.0001818885,0.001217866,0.005527637,0.0001304736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003377404,"about_ca_system_score_gemma":0.00152759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004325054,"about_ca_topic_score_gemma":0.0002278349,"domain_scores_codex":[0.987462,0.006498568,0.00203891,0.002293923,0.0006307052,0.001075912],"domain_scores_gemma":[0.9929299,0.005045179,0.0004319286,0.001050054,0.0001670426,0.000375863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002069176,0.0006955059,0.0001863026,0.002509081,0.00003318439,0.000133878,0.0002528244,1.010804e-7,0.0001070653,0.0006043049,0.002064345,0.9932065],"study_design_scores_gemma":[0.001800102,0.0008530514,0.001184956,0.008562585,0.00001941619,0.000009844453,0.0004648784,0.000002290492,0.0002132209,0.0005735758,0.9856845,0.000631571],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009850085,0.9858409,9.65852e-7,0.00006855378,0.0004168995,0.001525876,0.00006273164,0.00007249917,0.002161509],"genre_scores_gemma":[0.00591552,0.9914554,0.00003120013,0.0001014907,0.0006715042,0.0006061267,0.000006251828,0.0000891196,0.001123416],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9925749,"threshold_uncertainty_score":0.9998532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097478662","doi":"10.1158/1078-0432.ccr-08-3012","title":"<i>MSH6</i> Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":388,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Royal College of Physicians and Surgeons of Canada; Wellcome Trust","keywords":"Temozolomide; MSH6; Cancer research; Biology; Medicine; Glioma; DNA mismatch repair; DNA repair; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1633937970880163,"gpt":0.4951790380765004,"spread":0.3317852409884841,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00156521,0.0001781101,0.0005129497,0.0003138464,0.0001854736,0.0000501737,0.0001446799,0.0001755187,0.0001062407],"category_scores_gemma":[0.0008470193,0.0001418893,0.000116391,0.0007385967,0.0003850089,0.00009967898,0.00005713909,0.0008071149,0.00004227573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002264258,"about_ca_system_score_gemma":0.0002851858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002392082,"about_ca_topic_score_gemma":0.001403382,"domain_scores_codex":[0.9971336,0.0003386892,0.0006801995,0.000627605,0.0006041857,0.0006157192],"domain_scores_gemma":[0.9977204,0.001123935,0.00008309237,0.0004444328,0.0002205476,0.0004075963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007320992,0.002704485,0.8825201,0.0001198876,0.0001672016,0.00208029,0.0005950239,0.000020764,0.01107886,0.0004826445,0.00744488,0.08546486],"study_design_scores_gemma":[0.00818307,0.0007709173,0.9772546,0.0003230366,0.0000216662,0.00001401054,0.00008017289,0.00005240746,0.006304387,0.001492628,0.005352042,0.0001510899],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9703938,0.009568538,9.313028e-7,0.01793269,0.00008999333,0.0008108589,0.00001522944,0.00004512851,0.001142874],"genre_scores_gemma":[0.9826726,0.01528338,0.0002606402,0.0006146406,0.0002787678,0.0002521902,0.000008060477,0.00002396409,0.0006058129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09473445,"threshold_uncertainty_score":0.5786079,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2791308824","doi":"10.1158/1078-0432.ccr-17-3452","title":"Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Breast cancer; Internal medicine; Oncology; Adverse effect; Cancer; Response Evaluation Criteria in Solid Tumors; Estrogen receptor; Nausea; Gastroenterology; Phases of clinical research; Toxicity; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.06109298004932549,"gpt":0.4370445413124408,"spread":0.3759515612631153,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001027858,0.0002537565,0.0007856857,0.0002130682,0.0002126712,0.00002157816,0.0002070317,0.0001872202,0.001776652],"category_scores_gemma":[0.0002780981,0.000192448,0.0001247299,0.0007265909,0.002272012,0.0002583296,0.0001434074,0.0008487088,0.000008762104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005867533,"about_ca_system_score_gemma":0.0007950383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003990219,"about_ca_topic_score_gemma":0.0008644076,"domain_scores_codex":[0.9965217,0.0006016206,0.0006928317,0.0007261695,0.0008144678,0.0006432359],"domain_scores_gemma":[0.9972336,0.0005777781,0.0002598228,0.0003676374,0.001262545,0.0002985855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1027604,0.000735931,0.7898188,0.0001418992,0.0002776475,0.000004444007,0.0002762908,2.698322e-7,0.007446384,0.00002485278,0.0004017036,0.09811132],"study_design_scores_gemma":[0.01612655,0.003589353,0.9632673,0.0006955278,0.00002712833,0.000002130673,0.00006103801,0.000008211175,0.01541302,0.00001351736,0.0005845329,0.0002116861],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952664,0.0003202661,0.000006242271,0.001758118,0.0002024404,0.001212126,0.0008559481,0.00002114197,0.0003572971],"genre_scores_gemma":[0.9975245,0.001436674,0.0001385435,0.0001654608,0.0003493106,0.00009610609,0.00002574433,0.00004557508,0.0002180655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1734485,"threshold_uncertainty_score":0.9991359,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126372889","doi":"10.1158/1078-0432.ccr-06-2610","title":"Correlation between Development of Rash and Efficacy in Patients Treated with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large Phase III Studies","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Rash; Erlotinib; Internal medicine; Medicine; Gefitinib; Gemcitabine; Epidermal growth factor receptor; Erlotinib Hydrochloride; Hazard ratio; Gastroenterology; Oncology; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.1488288453879716,"gpt":0.5328739408514896,"spread":0.3840450954635181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001897061,0.0001357944,0.0004611663,0.0002186812,0.0001272493,0.000009495476,0.00006045941,0.00006917046,0.00003913179],"category_scores_gemma":[0.0006446711,0.00008062915,0.00003541189,0.0006426091,0.0002956017,0.00007615457,0.00007525795,0.0004719409,0.000003872217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004023862,"about_ca_system_score_gemma":0.0003953011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003520887,"about_ca_topic_score_gemma":0.001622036,"domain_scores_codex":[0.9977868,0.0002254348,0.0007676997,0.0003315342,0.0004912722,0.0003972489],"domain_scores_gemma":[0.9975196,0.001537474,0.0001332761,0.0001561693,0.0004968311,0.0001567154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002699398,0.001649504,0.9633865,0.00005602279,0.0001645662,0.00001062663,0.002380471,0.000001339138,0.00003655838,0.00001313563,0.0002585328,0.02934329],"study_design_scores_gemma":[0.03854463,0.0009327852,0.9577301,0.000388461,0.00005393369,1.756273e-7,0.0004832623,0.00001039876,0.001146743,0.000003818926,0.0006235939,0.00008208451],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970117,0.0006252473,0.0000245619,0.0006873345,0.00006389796,0.001469117,0.00004980177,0.00001071404,0.00005759998],"genre_scores_gemma":[0.9991195,0.0001548387,0.0001751977,0.0000538166,0.0001345832,0.00009666938,0.00009649489,0.00001830792,0.0001506115],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03584523,"threshold_uncertainty_score":0.3287961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129890171","doi":"10.1158/1078-0432.ccr-03-0561","title":"Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitors","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":381,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Bortezomib; Sodium butyrate; Apoptosis; Histone deacetylase inhibitor; Histone deacetylase; Proteasome inhibitor; Chemistry; Pharmacology; Cancer research; Biology; Multiple myeloma; Biochemistry; Histone; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.05259905812903075,"gpt":0.4263265050443159,"spread":0.3737274469152851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002735524,0.0002151286,0.0003643951,0.0001976361,0.0002816605,0.00004045053,0.0002900594,0.0003788379,0.00001391822],"category_scores_gemma":[0.00140784,0.000177781,0.00008482685,0.0004706405,0.002280043,0.00001944804,0.0004751732,0.001040809,0.00000416571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002232664,"about_ca_system_score_gemma":0.0004299155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002322038,"about_ca_topic_score_gemma":0.0007638549,"domain_scores_codex":[0.9965475,0.0007592078,0.0007458059,0.0007836169,0.0006204309,0.0005435068],"domain_scores_gemma":[0.9984779,0.0002563071,0.0001607724,0.0004923273,0.0003447541,0.0002679453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005260659,0.0003205338,0.002013658,0.00008555764,0.00003514764,0.000003151015,0.0001845022,0.00001615396,0.9872316,0.00003149999,0.004756657,0.004795466],"study_design_scores_gemma":[0.00198091,0.001094745,0.002354334,0.0001340583,0.000009843219,0.000001886123,0.0002674479,0.00001025374,0.9914126,0.0001023164,0.002434249,0.0001973825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959449,0.001865041,0.00002289151,0.0007712507,0.0001536438,0.00107611,0.00009585294,0.00000878882,0.00006156661],"genre_scores_gemma":[0.9977409,0.0009100753,0.0001005003,0.00004482757,0.0004161235,0.0003720216,0.00003754528,0.00004206766,0.0003359243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004598083,"threshold_uncertainty_score":0.8400912,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129520566","doi":"10.1158/1078-0432.ccr-20-4573","title":"Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Cancer Institute; National Institutes of Health; Progenics Pharmaceuticals","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Biochemical recurrence; Oncology; Radiology; Internal medicine; Prostatectomy","retraction":null,"screen_n_in":null,"score":{"opus":0.1496450702030405,"gpt":0.5127410395060567,"spread":0.3630959693030162,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003065973,0.0002744923,0.0008313131,0.0001261389,0.0001734238,0.0000567541,0.0004513106,0.0000349615,0.0004059726],"category_scores_gemma":[0.002781223,0.0001589862,0.0001333191,0.00113381,0.00101542,0.0001077922,0.0003909121,0.001743359,0.00002018616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004708965,"about_ca_system_score_gemma":0.002765632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005992009,"about_ca_topic_score_gemma":0.002650569,"domain_scores_codex":[0.9943357,0.0009087537,0.001266673,0.001044542,0.001557462,0.0008868723],"domain_scores_gemma":[0.9914441,0.00566479,0.000205157,0.0009929626,0.00130004,0.0003929829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0776784,0.008320112,0.8634253,0.0002340894,0.0007238716,0.004346787,0.00197709,0.00002929824,0.001395197,0.000002101693,0.008163407,0.03370431],"study_design_scores_gemma":[0.31687,0.01993598,0.5470556,0.008694903,0.0007048069,0.00005493701,0.01233202,0.004669157,0.07810613,0.00004962744,0.01061801,0.0009088471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807198,0.007864477,3.075044e-7,0.006637994,0.000186982,0.003530497,0.0005838827,0.00002222905,0.0004538522],"genre_scores_gemma":[0.9695565,0.02651633,0.00004131412,0.0001447158,0.0003279533,0.001376781,0.0002154978,0.00004327989,0.001777591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3163697,"threshold_uncertainty_score":0.9058165,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130808338","doi":"10.1158/1078-0432.ccr-09-1467","title":"MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":378,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Saskatchewan","funders":"National Institutes of Health; Howard Hughes Medical Institute","keywords":"Adenocarcinoma; Tissue microarray; Medicine; Esophagus; microRNA; Cancer; Carcinogenesis; Oncology; Carcinoma; Stage (stratigraphy); Pathology; Internal medicine; Esophageal cancer; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.06184540703168849,"gpt":0.3949153091517561,"spread":0.3330699021200676,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008650879,0.0000831188,0.0001511169,0.00004307137,0.00008022656,0.00001417876,0.0002325083,0.0001547366,0.00001243068],"category_scores_gemma":[0.0002691928,0.00005864134,0.00005990147,0.0002102505,0.0002262577,0.000004189524,0.0001309877,0.0002681576,8.929879e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004236648,"about_ca_system_score_gemma":0.0002872059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009886045,"about_ca_topic_score_gemma":0.0001898348,"domain_scores_codex":[0.9983946,0.0004645592,0.000296215,0.0003198916,0.0002888602,0.0002358902],"domain_scores_gemma":[0.999141,0.00012488,0.0001006852,0.0003602029,0.000188893,0.00008437371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002473612,0.0001462017,0.8283446,0.0000179842,0.000003648061,0.000002077312,0.00003955478,0.00002115358,0.1700704,0.00001078935,0.0006434007,0.0004528577],"study_design_scores_gemma":[0.0009062423,0.000262032,0.8218706,0.00001788439,0.00000623744,5.979124e-7,0.00003709736,0.00001650338,0.1766723,0.00006438939,0.00008747617,0.00005866208],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886892,0.01029176,0.00001129533,0.0004796401,0.00004965605,0.0002912198,0.00002988021,0.000002365255,0.0001549833],"genre_scores_gemma":[0.9994099,0.00009220692,0.00008111691,0.0000578074,0.0001430799,0.0000165103,0.00001427806,0.00001056312,0.0001745901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01072065,"threshold_uncertainty_score":0.2391325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2792841925","doi":"10.1158/1078-0432.ccr-17-3089","title":"<i>DICER1</i> and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Identification (biology); Environmental health; Medicine; Risk assessment; Computer security; Computer science; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.3394422382492218,"gpt":0.5825319509312992,"spread":0.2430897126820774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009728348,0.0002727911,0.002200659,0.0002504035,0.0002550447,0.00007620128,0.000195345,0.0004718977,0.0002280282],"category_scores_gemma":[0.01039808,0.0002167672,0.0002392994,0.0005828477,0.001464135,0.00007886382,0.0004914541,0.001080345,0.00005406744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002244032,"about_ca_system_score_gemma":0.0008875305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001904829,"about_ca_topic_score_gemma":0.0007390674,"domain_scores_codex":[0.9940693,0.00224178,0.00186763,0.0006884207,0.0007304277,0.0004023998],"domain_scores_gemma":[0.9892553,0.008200556,0.0008985384,0.0005160826,0.0008927798,0.0002367235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001052766,0.0003745255,0.05194972,0.02537801,0.003043888,0.00001235428,0.0003186848,1.757e-8,0.000003767417,0.00007466204,0.03075473,0.8879843],"study_design_scores_gemma":[0.001892763,0.0007310972,0.1342107,0.01345106,0.001510194,0.00001643041,0.0003542235,0.000008552504,0.000002885992,0.0011962,0.8462191,0.0004067655],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02496306,0.9704783,8.316598e-7,0.0003388132,0.0001765292,0.001614747,0.0016989,0.00003073115,0.0006980918],"genre_scores_gemma":[0.007524798,0.9905967,0.00001966718,0.00002828288,0.0002201056,0.0004542484,0.0002445868,0.00004419308,0.0008674663],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8875776,"threshold_uncertainty_score":0.9979377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}